Keith W. Pfeil - 19 Jul 2021 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role: SVP, Chief Financial Officer
Signature: /s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol: GMED
Transactions as of: 19 Jul 2021
Net transactions value: -$23,852
Form type: 4
Filing time: 20 Jul 2021, 16:20:50 UTC
Previous filing: 06 Jul 2021
Next filing: 03 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GMED	Class A Common Stock	Options Exercise	$41,408	+834		$49.65	834	19 Jul 2021	Direct
transaction	GMED	Class A Common Stock	Sale	$65,260	-834	-100%	$78.25	0	19 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMED	Stock Option (Right to Buy Class A Common Stock)	Options Exercise	$0	-834	-3.8%	$0.000000	20,833	19 Jul 2021	Class A Common Stock	834	$49.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2	These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.